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Purpose: To prepare and evaluate floating microspheres of silymarin for prolonged gastric residence 
time and increased drug bioavailability. 
Methods: Cellulose microspheres – formulated with hydroxylpropyl methylcellulose (HPMC) and ethyl 
cellulose (EC) – and Eudragit microspheres – formulated with Eudragit
®
 S 100 (ES) and Eudragit
®
 RL 
(ERL) - were prepared by an emulsion-solvent evaporation method. The floating microspheres were 
evaluated for flow properties based on parameters such as angle of repose and compressibility index, 
as well as for various other physicochemical properties including particle size, incorporation efficiency, in 
vitro floatability, and in vitro drug release. The shape and surface morphology of the microspheres were 
characterised by optical and scanning electron microscopy. 
Results: Mean particle size increased while drug release rate decreased with increasing EC and ES 
contents of cellulose and Eudragit microspheres, respectively. Scanning electron microscopy showed 
pores on the surface and interior of the microspheres. The microspheres exhibited prolonged drug 
release for 12 h while still remained buoyant. Drug release kinetics, evaluated using the linear 
regression method, followed Higuchi kinetics and drug release mechanism was of the non-Fickian type. 
Conclusion: The developed floating microspheres of silymarin exhibited prolonged drug release in 
simulated gastric fluid for at least 12 h, and, therefore, could potentially improve the bioavailability of the 
drug as well as patient compliance. 
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INTRODUCTION 
 
Oral sustained drug delivery may be 
complicated by limited gastric residence time. 
Rapid gastrointestinal transit can prevent 
complete drug release in the absorption zone 
and reduce the efficacy of administered dose 
since the majority of drugs are absorbed in 
the stomach or the upper part of the small 
intestine.  
 
Dosage forms that can be retained in the 
stomach are called gastroretentive drug 
delivery systems (GRDDS) [1]. 
Gastroretentive floating drug delivery 
systems (GRFDDS) have a bulk density 
lower than that of gastric fluids and thus 
remains buoyant in the stomach without 
affecting gastric emptying rate for a 
prolonged period of time [2]. While the 
system is floating on gastric contents, the 
drug is released slowly at a desired rate from 
the system. Both single and multiple unit 
systems have been developed. The single 
unit floating system is more popular but has 
the disadvantage that its purpose would not 
be achieved if it fails to float, or is rapidly 
emptied from the stomach since there is high 
variability of gastrointestinal transit time [3]. 
On the other hand, a floating system made 
up of multiple units may be better suited 
because they are claimed to reduce 
intersubject variability in absorption and also 
lower the probability of dose dumping [4].   
 
Silymarin is a standardised seed extract 
which is rich in a type of flavonoid 
compounds known as flavonolignans [5]. The 
main flavonolignans in silymarin are the 
isomers, silybin (also known as silibinin), 
silydianin, and silychristin. Silymarin acts as 
an antioxidant, scavenger and regulator of 
the intracellular content of glutathione, cell 
membrane stabiliser and permeability 
regulator to prevent hepatotoxic agents from 
entering hepatocytes. It also acts as a 
promoter of ribosomal RNA synthesis [6], 
stimulator of liver regeneration and inhibitor 
of the transformation of stellate hepatocytes 
into myofibroblasts - the process responsible 
for the deposition of collagen fibres, leading 
to cirrhosis.  
Silymarin is poorly soluble in water and, 
therefore, an acidic medium is essential for 
its dissolution. Its dose is 70 - 140 mg three 
times a day and has low bioavailability. The 
low bioavailability of the drug is due to rapid 
biotransformation in the liver, and has a 
biological half-life of 6 h. Its reatively short 
half-life, poor bioavailability and lipophillic 
nature make it a suitable candidate for 
gastroretentive drug delivery system.  
 
The objective of this work was to develop and 
characterise gastroretentive floating 
microspheres of silymarin which, following 
oral administration, would exhibit prolonged 
gastric residence time and, hence increase 






Silymarin was received as a gift from Micro 
Lab India. Eudragit S 100 (ES100) and 
Eudragit RL (ERL) were obtained from Rohm 
Pharma, Darmstadt, Germany while polyvinyl 
alcohol (PVA), hydrochloric acid (HCl), 
Tween 80, hydroxylpropyl methylcellulose 
(HPMC) and ethyl cellulose (EC) were 
procured from Central Drug House, New 
Delhi. Dichloromethane and ethanol were 
purchased from E. Merck (India) Ltd, 
Mumbai. All the other chemicals used were of 
analytical grade. 
 
Preparation of microspheres  
 
Floating microspheres, comprising silymarin 
and total polymer in a 1:1 ratio, were 
prepared by emulsion solvent diffusion 
technique [7] with some modifications. The 
composition of the microspheres is shown in 
Table 1. 
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Organic solvent ratio 
(dichloromethane: ethanol) 
HE1 HPMC:EC 1:1 1:1 
HE2 HPMC:EC 1:2 1:1 
HE3 HPMC:EC 1:3 1:1 
HE4 HPMC:EC 1:4 1:1 
RLS1 ERL: ES 0:2 1:1 
RLS2 ERL: ES 0.5:1.5 1:1 
RLS3 ERL: ES 1:1 1:1 
RLS4 ERL:  ES 1.5:0.5 1:1 
 
Cellulose microspheres  
 
The polymer content was a mixture of 
HPMC:EC (1 g) in ratios of 1:1 (HE1), 1:2 
(HE2), 1:3 (HE3) and 1:4 (HE4). The drug 
and polymer (in a ratio of 1:1) were dissolved 
in a 20 ml mixture of dichloromethane and 
ethanol (1:1) at room temperature. The 
solution was poured slowly as a thin stream 
into 150 ml of 0.01 % Tween 80 maintained 
at 30 - 40 
0
C. The emulsion was continuously 
stirred at a rotation speed of 300 rpm for 1 h 
to allow the volatile solvents to evaporate. 
The floating microspheres were collected by 
decantation while the non-floating 
microspheres were discarded along with 
polymer residues. The collected micro-
spheres were dried overnight in an oven at 
40 ± 2 
0
C and stored in a desiccator 




The polymer content of the microspheres was 
a mixture of ES and ERL in ratios of 0:2 
(RLS1), 0.5:1.5 (RLS2), 1:1 (RLS3) and 
1.5:0.5 (RLS4). The drug and polymer blend 
(20 ml), in a ratio of 1:1, were dissolved in a 
mixture of dichloromethane and ethanol (1:1) 
at room temperature. The solution was 
poured slowly as a thin stream into 150 ml of 
0.2 % sodium lauryl sulphate solution 
maintained at 30 - 40 
0
C. The emulsion was 
continuously stirred at a rotation speed of 300 
rpm for 1 h to allow volatile solvents to 
evaporate. The floating microspheres were 
collected by decanting, while the non-floating 
microspheres were discarded along with 
residues of the polymers. The collected 
microspheres were dried in an oven overnight 
at 40 ± 2 
0
C and stored in a calcium chloride 
desiccator. 
 
Evaluation of silymarin and microspheres 
Authentication of silymarin  
 
Identification of silymarin was by comparison 
with that of an authentic sample and by 
verification of the presence of functional 
groups in its infra-red (IR) spectra. Also, 
various concentrations of the drug in 0.1M 
HCl were evaluated by ultraviolet (UV) 
spectroscopy (Shimadzu –1700) to determine 
if it would obey Beer’s law. 
 
Particle size determination 
 
The particle size of the microspheres was 
determined with an optical microscope under 
regular polarised light, and mean particle size 
was calculated by measuring 100 
microspheres (n = 3) with the help of a 
calibrated oculometer [8]. 
 
Tapped density   
 
Tapping method was used to calculate 
tapped density. The volume of a weighed 
quantity of the microspheres was determined, 
after 100 taps, using a tapped density 
apparatus (Pharma Chem Machineries, 
model C-BD 100), as in Eq. 1. 
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DT = MT/VT ……………….………………..  (1) 
 
where DT = tapped density,  MT is mass of 
microspheres and VT = volume of 
microspheres after tapping  
 
Carr’s (Compressibility) index  
 
This parameter was calculated from bulk 
density (the ratio of weighed quantity of 
microspheres to its volume), DP, and tapped 
density as in Eq 2 [9] 
 
 
Compressibility index = (DT – DP)/DTx100 …...   (2) 
 
Angle of repose 
  
The angle of repose, θ, of the microspheres, 
which measures resistance to particle flow, 
was determined by the fixed funnel method 
[10] and calculated
 
 as in Eq 3. 
 
Tan θ = S/D  ……………………………....   (3) 
 
where S = surface area of the free standing 
height of the microspheres heap and D = 
diameter of the heap. 
 
Scanning electron microscopy  
 
Scanning electron microscopy (SEM) studies 
were performed to determine the 
porous/hollow nature of the microspheres. 
Surface morphology of microspheres was 




The drug content of the floating microspheres 
was carried out by dissolving the 
microspheres in a small amount of 
dichloromethane in a separating funnel and 
extracting the drugs into 0.1N HCl by 
evaporating the dichloromethane. 
Determination of drug loading (n = 3) was 
carried out at 288 nm spectrophoto-metrically 
(Shimadzu 1700). 
 
In vitro floatability   
 
In vitro floatability studies on floating 
microspheres were carried out using USP 
XXIV dissolution apparatus II [11]. The 
microspheres were placed in 0.1M 
hydrochloric acid containing 0.02 %v/v 
Tween 80 with the paddle rotating at 100 rpm 
for 12 h. Tween 80 served to mimic the effect 
of natural surfactants in the stomach. The 
floating and the settled portions of the 
microspheres were recovered separately, 
dried and weighed. Buoyancy (floatability) 
was calculated as in Eq 4. 
 
Buoyancy (%) = Qf / (Qf + Qs) x 100  .….  (4) 
 
where Qf and Qs are the weights of the 
floating and the settled microspheres, 
respectively. 
 
In vitro drug release studies   
 
Drug release studies were carried out in a 
six-basket USP XXIV dissolution apparatus 
type I rotating at 100 rpm in 0.1M 
hydrochloric acid as dissolution medium (900 
ml) maintained at 37 ± 0.5 °C. At specific time 
intervals, up to 12 h, aliquots were withdrawn 
and analysed at 288 nm 
spectrophotometrically (Shimadzu 1700) after 
suitable dilution. The withdrawn volume was 
replaced with an equal volume of fresh 0.1M 
hydrochloric acid to maintain sink conditions. 
All experiments were performed in triplicate. 
The drug release data were fitted to Zero 
order (cumulative % drug release versus 
time), First order (log cumulative % drug 
retained versus time) and Higuchi models 
(cumulative % drug released versus square 
root of time) to assess the kinetics of drug 
release and determine the release 





Data of two sets were evaluated by paired t-
test and one-way analysis of variance 
(ANOVA) were applied to check significant 
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difference in drug release from different 
formulations.  p values of less than 0.05 (p < 






The IR spectra showed peaks at 3449.3, 
2926.8, 2366.1, 1741.3, 1083.2 and 1027.8 
cm
-1
. which are consistent with the presence 
of the functional groups of silymarin. 
Furthermore, the calibration curve of 
silymarin obeyed Beer’s law in the range of 
20 - 55 µg/ml.  
 
Physical properties of microspheres 
 
The mean particle size of the microspheres 
significantly increased (p < 0.05) with 
increasing polymer concentration. Particle 
size was in the range of 220.4 ± 3.7 to 247.6 
± 3.1 µm for cellulose microspheres and 
251.3 ± 3.9 to 282.7 ± 5.2µm for Eudragit 
microspheres, as shown in Table 2.  
Angle of repose for cellulose microspheres 
was between 27.8 and 33.1 º, and 32.2 to 
41.3 º for Eudragit microspheres, thus 
indicating good flow property for both types of 
microspheres. The findings were supported 
by Carr’s (compressibility) index, which was < 
20 indicating good flow characteristics (Table 
2).  
 
The production yield of floating microspheres 
was greater than 65 % for all the 
formulations. In the floatation test, more than 
75 % of cellulose microspheres and 61 % of 
Eudragit microspheres remained floating at 
the end of 12 h (Table 2).  
 
The encapsulation efficiency of the prepared 
microspheres was in the range 85.1±2.3 to 
94.2±1.4 for cellulose microspheres and 
87.7±2.6 to 72.8±3.7 for Eudragit 
microspheres. Scanning electron microscopy 
revealed pores on the microsphere as well as 
a hollow microsphere interior (see Fig 1).  
 
 
























efficiency (%)  
% 
Buoyancy 
HE1 220.4 ± 3.7 0.582 0.692 15.89 27.76 85.1 ± 2.3 75.7 
HE2 232.8 ± 4.5 0.547 0.676 19.08 33.13 87.4 ± 4.8 82.5 
HE3 239.1 ± 2.8 0.530 0.678 18.86 31.40 88.5 ± 5.7 90.4 
HE4 247.6 ± 3.1 0.410 0.497 17.50 30.50 94.2 ± 1.4 94.1 
RLS1 282.7 ± 5.2 0.631 0.757 16.64 32.21 87.7 ± 2.6 68.1 
RLS2 272.9 ± 4.7 0.535 0.642 16.67 34.55 83.4 ± 3.5 79.8 
RLS3 261.9 ± 3.5 0.473 0.578 18.17 35.83 77.8 ± 4.3 84.4 




Fig 1: Typical scanning electron microphotographs (SEM) of the developed floating  
   microspheres 
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In the in vitro drug release studies, the 
highest cumulative drug released by the 
cellulose microspheres after 12 h was 70 ± 
2.7 % and this was for HE1, i.e., the 
formulation with the lowest content of ethyl 
cellulose. Maximum drug released for HE2, 
HE3 and HE4 was 68.0 ± 1.4, 65.0 ± 1.5  and 
58.0 ± 2.2 %, respectively (see Figure 2A). 
For the Eudragit microspheres, the 
formulation with the highest content of ERL 
(i.e., RLS4) showed a maximum drug release 
of 46.2 ± 1.7 %. Maximum drug release 
decreased to 37.5 ± 2.2, 35.73 1.5 and 32.2 ± 
2.1 % for RLS3, RLS2 and RLS1, 




















Fig 2:  In vitro release profile of silymarin from 
cellulose floating microspheres in 0.1M HCl 
 
Note: (A) ♦ = HE1; ▪ = HE2; □ = HE3; - = HE4, 
and from Eudragit floating microspheres (B): ♦ = 




Cellulose microspheres were prepared by 
gradually increasing EC concentration in 
combination with a fixed concentration of 
HPMC in order to assess the effect of 
polymer (especially EC) concentration on 
microsphere size. It would be expected that 
the viscosity of the polymer mixture would 
increase as polymer concentration rose, 
resulting in enhanced interfacial tension and 
hence, formation of larger particles. The 
mean particle size of Eudragit microspheres 
was greater than that of cellulose 
microspheres, and this may be viscosity-
related. All the microsphere formulations 
showed excellent flowability as represented 
by angle of repose (≤ 35 º), except for RLS4 
and this might be due to its high content of 
ERL. 
 
Encapsulation efficiency rose with increase in 
EC concentration for cellulose microspheres 
while for Eudragit microspheres, this 
parameter decreased with increase in ERL 
content. This could be due to the higher 
permeability characteristics of HPMC and 
ERL which would facilitate the diffusion of 
part of the entrapped drug to the surrounding 
medium during the preparation of the 
microparticles.  
 
The SEM images in Fig 1 showed the 
spherical and hollow nature of the 
microspheres as well as the presence of 
pores on their surface. Their sphericity 
contributed considerably to their very good 
flow properties while their hollow nature 
would mean lower microsphere density. A 
large proportion of the microspheres – 61 and 
75 % for Eudragit and cellulose 
microspheres, respectively – remained 
floating after 12 h. This period was sufficient 
for up to 70 % of cellulose microspheres 
(HE1) and 46 % of the Eudgragit 
microspheres (RLS4) to be released. Thus, 
prolonged floatation was achieved without 
apparent gelation. Floatation might have 
been influenced by the low bulk and tapped 
densities of the microspheres. Microspheres 
with the highest levels pf ERL (RLS4) and 
HPMC (HE1) were least buoyant. It is likely 
that the surfactant incorporated in the 
formulations would have increased their 
wettability and hence, hydration, more than in 
A 
B 
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the other microspheres which had lower 
levels of the permeable ERL and HPMC.  
Consequently, the increased amount of 
absorbed liquid medium replaced the air 
inside the floating microspheres, thus 
rendering them less buoyant [12,13].  
 
Silymarin release from cellulose 
microspheres decreased with increasing EC 
concentration. Increase in the content of EC 
(which is less permeable than HPMC) would 
increase polymer matrix density and thus 
result in increased diffusional pathlength, 
leading to a decrease in drug release from 
the microsphere. Another factor might be that 
the smaller microspheres formed at low EC 
concentration had a larger surface area 
exposed to the dissolution medium, thus, 
giving rise to faster drug release.  
On the other hand, the greater the content of 
ERL, the higher was the rate of drug release 
from Eudragit microspheres. ES is insoluble 
in acidic medium and also exhibits low 
permeability [14]. It is an anionic copolymer 
of methacrylic acid and methyl methacrylate 
containing free carboxylic and ester groups. 
Its very low permeability results from the high 
intermolecular attraction between its 
molecules. Hydrogen bonding between the 
hydroxyl groups of the carboxylic moiety and 
the carbonyl oxygen of ester group increases 
the degree of compactness of the polymer 
and decreases its porosity and permeability. 
ERL, however, is a copolymer of acrylic and 
methacrylic acid esters with a low content of 
quaternary ammonium groups. The 
ammonium groups present as salts promotes 
permeability and act as a channeling agent 
for the entrance of the liquid medium through 
the floating microsphere wall, causing it to 
swell. This facilitates the diffusion of the 
dissolved drug out of the microsphere into the 
dissolution medium. Thus, by varying the 
ratio of HPMC and EC in the cellulose 
microspheres, and ES and ERL in Eudragit 
microspheres,  the rate of release of silymarin 
can be controlled. 
 
The zero order plots of different formulation 
were found to be fairly linear, as indicated by 
their high regression values (R
2
 = 0.9700 - 
0.9984). Thus, it seems that drug release 
from the floating microspheres followed Zero 
order kinetics. Data based on the Higuchi 
model usually provide a clue to the diffusion 
mechanism of drug release from matrix 
systems such as the floating microspheres 
developed in this work. R
2
 values  based on 
the Higuchi model ranged from 0.9680 to 
0.9991 (Table 3). As these values were close 
to 1.0, the drug release mechanism of the 
developed floating microspheres can be said 
to be Higuchian and, therefore, matrix 
diffusion-controlled.  
 
Table 3: Regression coefficients (R
2
) derived from 
release data for various formulations using 











HE1 0.97 0.9993 0.9991 
HE2 0.9936 0.990 0.9866 
HE3 0.9984 0.9839 0.9843 
HE4 0.9975 0.9941 0.9886 
RLS1 0.9974 0.9940 0.9680 
RLS2 0.9946 0.9927 0.9735 
RLS3 0.9908 0.9936 0.9762 





We can conclude that floating microspheres 
of silymarin prepared with a suitable blend of 
ES and ERL on the one hand, and HPMC 
and EC on the other, demonstrate 
satisfactory release and floating properties. 
The developed floating microspheres also 
showed good physicochemical properties. 
Drug release from the formulations followed 
Zero order kinetics and the mechanism of 
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